| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 2044 | 2017 |
| Poly (ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease TI Kam, X Mao, H Park, SC Chou, SS Karuppagounder, GE Umanah, ... Science 362 (6414), eaat8407, 2018 | 469 | 2018 |
| Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? JL Whitwell, GU Höglinger, A Antonini, Y Bordelon, AL Boxer, C Colosimo, ... Movement Disorders 32 (7), 955-971, 2017 | 249 | 2017 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 224 | 2020 |
| Which ante mortem clinical features predict progressive supranuclear palsy pathology? G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ... Movement Disorders 32 (7), 995-1005, 2017 | 174 | 2017 |
| How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy MJ Grimm, G Respondek, M Stamelou, T Arzberger, L Ferguson, E Gelpi, ... Movement disorders 34 (8), 1228-1232, 2019 | 134 | 2019 |
| Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction CA Ross, A Pantelyat, J Kogan, J Brandt Movement disorders 29 (11), 1351-1358, 2014 | 122 | 2014 |
| Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ... Alzheimer's & Dementia 16 (1), 106-117, 2020 | 121 | 2020 |
| A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the … SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ... Acta neuropathologica 138, 237-250, 2019 | 118 | 2019 |
| Music therapy and music-based interventions for movement disorders K Devlin, JT Alshaikh, A Pantelyat Current Neurology and Neuroscience Reports 19, 1-13, 2019 | 105 | 2019 |
| Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study E Jabbari, S Koga, RR Valentino, RH Reynolds, R Ferrari, MMX Tan, ... The Lancet Neurology 20 (2), 107-116, 2021 | 104 | 2021 |
| Global survey on telemedicine utilization for movement disorders during the COVID‐19 pandemic A Hassan, Z Mari, EM Gatto, A Cardozo, J Youn, N Okubadejo, JA Bajwa, ... Movement Disorders 35 (10), 1701-1711, 2020 | 97 | 2020 |
| Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration JC Rojas, P Wang, AM Staffaroni, C Heller, Y Cobigo, A Wolf, SYM Goh, ... Neurology 96 (18), e2296-e2312, 2021 | 81 | 2021 |
| Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations TS Aleman, AV Cideciyan, EAM Windsor, SB Schwartz, M Swider, ... Investigative ophthalmology & visual science 48 (3), 1319-1329, 2007 | 79 | 2007 |
| Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies JT Geiger, J Ding, B Crain, O Pletnikova, C Letson, TM Dawson, ... Neurobiology of disease 94, 55-62, 2016 | 75 | 2016 |
| Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ... Alzheimer's & Dementia, 2019 | 67 | 2019 |
| Best practices in the clinical management of progressive supranuclear palsy and corticobasal syndrome: a consensus statement of the CurePSP Centers of Care B Bluett, AY Pantelyat, I Litvan, F Ali, D Apetauerova, D Bega, L Bloom, ... Frontiers in Neurology 12, 694872, 2021 | 64 | 2021 |
| Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases EM Ramos, DR Dokuru, V Van Berlo, K Wojta, Q Wang, AY Huang, ... Alzheimer's & Dementia 16 (1), 118-130, 2020 | 62 | 2020 |
| Validation of the movement disorder society criteria for the diagnosis of 4‐repeat tauopathies G Respondek, MJ Grimm, I Piot, T Arzberger, Y Compta, E Englund, ... Movement Disorders 35 (1), 171-176, 2020 | 57 | 2020 |
| DRUM‐PD: The use of a drum circle to improve the symptoms and signs of Parkinson's disease (PD) A Pantelyat, C Syres, S Reichwein, A Willis Movement disorders clinical practice 3 (3), 243-249, 2016 | 57 | 2016 |
